TGFB1 and inflammatory bowel disease: Statistically significant differences were found between TGF-β1 mRNA levels in changed and unchanged tissues when the whole group of IBD was analyzed (p < 0.001) as well as in the CD and UC subgroups (p < 0.001 in both cases), namely, the levels in the changed tissue samples were higher than in unchanged tissue samples (Fig. 1).